Charles Schwab Investment Management Inc Silverback Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 427,477 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
427,477
Previous 423,947
0.83%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SBTX
# of Institutions
178Shares Held
70.2MCall Options Held
218KPut Options Held
329K-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY10.5MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...